← Browse by Condition
Medical Condition

healthy adults

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1

Clinical trials often recruit healthy volunteers for Phase 1 pharmacokinetic and safety studies, vaccine immunogenicity assessments, and normal physiological reference studies. These trials are essential for establishing safe dose ranges and understanding how drugs behave in the absence of disease before testing in patient populations.

Healthy volunteer studies include first-in-human drug trials, vaccine efficacy (flu, RSV, COVID-19, malaria), microbiome intervention studies, exercise physiology research, and device safety assessments. Compensation is often provided; eligibility typically requires no significant medical history and a negative drug screen.

Healthy volunteer trials require participants to be in good general health with no significant medications. Many exclude smokers, pregnant individuals, and those with recent prior trial participation.

Frequently Asked Questions — healthy adults Clinical Trials

How many clinical trials are currently recruiting for healthy adults?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for healthy adults, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for healthy adults?
healthy adults research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a healthy adults clinical trial?
Eligibility criteria for healthy adults trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Monell Chemical Senses Center 1 trial
dsm-firmenich Switzerland AG 1 trial
Kaohsiung Medical University Chung-Ho Memorial Hospital 1 trial
Kırıkkale University 1 trial
University of Toronto 1 trial

Recruiting Clinical Trials

NCT06929455
Recruiting
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
Enrollment
100 pts
Location
United States
Sponsor
Monell Chemical Senses Center
View Trial →
NCT07880925 Phase 1
Recruiting
Effects of Trigonelline Monohydrate on NAD+ Metabolism, Pharmacokinetics, Safety, and Tolerability in Healthy Adults
Enrollment
60 pts
Location
Canada
Sponsor
dsm-firmenich Switzerland AG
View Trial →
NCT06011018
Recruiting
Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke
Enrollment
72 pts
Location
Taiwan
Sponsor
Kaohsiung Medical University C...
View Trial →
NCT06994793
Recruiting
Validity and Reliability of Gait and Jump Parameters Measured by the iSen Device in Healthy Adults
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Kırıkkale University
View Trial →
NCT07829237
Recruiting
FueL Use During eXercise in Males and Females
Enrollment
24 pts
Location
Canada
Sponsor
University of Toronto
View Trial →

Related Conditions

nad metabolism (1) pharmacokinetics (1) bioavailability (1) stroke (1) gait analysis (1) jumping performance (1) reliability and validity (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology